From my understanding, for medical devices to be sold in China, they require CE mark
1. But to get a CE mark, you need to conduct your clinical studies in the EU(?) population. (is my understanding correct?)
2. If your IVD is planned to be sold only in China because the assay tests for the presence of analytes/VIRAL STRAINS that are unique to that geographic region/population, how can you properly validate your test/clinical performance in clinical trials if the CE Mark requires you to test in the EU-where the strain youre testing for is so much more rarer than if you did clinical trials in China??
Appreciate any input here, thank you everyone!
1. But to get a CE mark, you need to conduct your clinical studies in the EU(?) population. (is my understanding correct?)
2. If your IVD is planned to be sold only in China because the assay tests for the presence of analytes/VIRAL STRAINS that are unique to that geographic region/population, how can you properly validate your test/clinical performance in clinical trials if the CE Mark requires you to test in the EU-where the strain youre testing for is so much more rarer than if you did clinical trials in China??
Appreciate any input here, thank you everyone!